test and colonoscopy every 10 yr.
a) Women at the time of menopause should consider testing for endometrial cancer. Any unexpected vaginal bleeding or spotting should be reported to a physician immediately.
References
1 1 Rossouw, J.E., Anderson, G.L., Prentice, R.L. et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (3): 321–333.
2 2 Anderson, G.L., Limacher, M., Assaf, A.R. et al. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 (14): 1701–1712.
3 3 LaCroix, A.Z., Chlebowski, R.T., Manson, J.E. et al. (2011). Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 305 (13): 1305–1314.
4 4 Chlebowski, R.T., Anderson, G., Pettinger, M. et al. (2008). Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Archives of Internal Medicine 168 (4): 370–377.
5 5 Chlebowski, R.T., Kuller, L.H., Prentice, R.L. et al. (2009). Breast cancer after use of estrogen plus progestin in postmenopausal women. New England Journal of Medicine 360 (6): 573–587.
6 6 Chlebowski, R.T., Schwartz, A.G., Wakelee, H. et al. (2009). Estrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post‐hoc analysis of a randomised controlled trial. Lancet 374 (9697): 1243–1251.
7 7 Crandall, C.J., Hovey, K.M., Andrews, C.A. et al. (2018). Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause 25 (1): 11–20.
8 8 Holmberg, L. and Anderson, H. (2004). HABITS (hormonal replacement therapy after breast cancer – is it safe?), a randomised comparison: trial stopped. Lancet 363 (9407): 453–455.
9 9 Pachman, D.R., Jones, J.M., and Loprinzi, C.L. (2010). Management of menopause‐associated vasomotor symptoms: current treatment options, challenges and future directions. International Journal of Women's Health 2: 123–135.
10 10 Franco, O.H., Chowdhury, R., Troup, J. et al. (2016). Use of plant‐based therapies and menopausal symptoms: a systematic review and meta‐analysis. JAMA 315 (23): 2554–2563.
11 11 Flegal, K.M., Kruszon‐Moran, D., Carroll, M.D. et al. (2016). Trends in obesity among adults in the United States. JAMA 315 (21): 2284–2291.
12 12 Kushi, L.H., Doyle, C., McCullough, M. et al. (2012). American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA: A Cancer Journal for Clinicians 62 (1): 30–67. https://doi.org/10.3322/caac.20140. PMID: 22237782.
13 13 Bleyer, A. (2007). Young adult oncology: the patients and their survival challenges. CA: A Cancer Journal for Clinicians 57: 242–255.
14 14 Lam, J.U., Rebolj, M., Dugué, P.A. et al. (2014). Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies. Journal of Medical Screening 21 (1): 38–50.
15 15 Winer, R.L., Hughes, J.P., Feng, Q. et al. (2006). Condom use and the risk of genital human papillomavirus infection in young women. The New England Journal of Medicine 354: 2645–2654.
16 16 Hales, C.M., Fryar, C.D., Carroll, M.D. et al. (2018). Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007–2008 to 2015–2016. JAMA 319 (16): 1723–1725.
17 17 Thomson, C.A., McCullough, M.L., Wertheim, B.C. et al. (2014). Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women's health initiative. Cancer Prevention Research (Philadelphia, Pa.) 1: 42–53.
18 18 Rock, C.L., Thomson, C., Gansler, T. et al. (2020). American Cancer Society guideline for diet and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians 70 (4): 245–271. https://doi.org/10.3322/caac.21591. Epub 9 June 2020. PMID: 32515498.
19 19 Bagnardi, V., Rota, M., Botteri, E. et al. (2013). Light alcohol drinking and cancer: a meta‐analysis. Annals of Oncology 24 (2): 301–308.
20 20 Bagnardi, V., Rota, M., Botteri, E. et al. (2015). Alcohol consumption and site‐specific cancer risk: a comprehensive dose‐response meta‐analysis. British Journal of Cancer 112 (3): 580–593.
21 21 Cao, Y., Willett, W.C., Rimm, E.B. et al. (2015). Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies. BMJ 351: h4238.
22 22 Chen, W.Y., Rosner, B., Hankinson, S.E. et al. (2011). Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 306 (17): 1884–1890.
23 23 White, A.J., DeRoo, L.A., Weinberg, C.R., and Sandler, D.P. (2017). Lifetime alcohol intake, binge drinking behaviors, and breast cancer risk. American Journal of Epidemiology 186 (5): 541–549.
24 24 Fan, X., Peters, B.A., Jacobs, E.J. et al. (2018). Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults. Microbiome 6 (1): 59.
25 25 Rehm, J., Patra, J., and Popova, S. (2007). Alcohol drinking cessation and its effect on esophageal and head and neck cancers: a pooled analysis. International Journal of Cancer 121 (5): 1132–1137.
26 26 Ahmad Kiadaliri, A., Jarl, J., Gavriilidis, G., and Gerdtham, U.G. (2013). Alcohol drinking cessation and the risk of laryngeal and pharyngeal cancers: a systematic review and meta‐analysis. PLoS One 8 (3): e58158.
27 27 Chao, C., Haque, R., Caan, B.J. et al. (2010). Red wine consumption not associated with reduced risk of colorectal cancer. Nutrition and Cancer 62 (6): 849–855.
28 28 Wu, C., Wang, Z., Song, X. et al. (2014). Joint analysis of three genome‐wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nature Genetics 46 (9): 1001–1006.
29 29 Vartolomei, M.D., Kimura, S., Ferro, M. et al. (2018). The impact of moderate wine consumption on the risk of developing prostate cancer. Clinical Epidemiology 10: 431–444.
30 30 Yokoyama, A. and Omori, T. (2005). Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers exit disclaimer. Alcohol 35 (3): 175–185.
31 31 Kanda, J., Matsuo, K., Suzuki, T. et al. (2009). Impact of alcohol consumption with polymorphisms in alcohol‐metabolizing enzymes on pancreatic cancer risk in Japanese. Cancer Science 100 (2): 296–302.
32 32 Nelson, D.E., Jarman, D.W., Rehm, J. et al. (2013). Alcohol‐attributable cancer deaths and years of potential life lost in the United States. American Journal of Public Health 103 (4): 641–648.
33 33 LoConte, N.K., Brewster, A.M., Kaur, J.S. et al. (2018). Alcohol and cancer: a statement of the American Society of clinical oncology. Journal of Clinical Oncology 36 (1): 83–93.
34 34 Hashibe, M., Brennan, P., Chuang, S.C. et al. (2009). Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiology, Biomarkers & Prevention 18 (2): 541–550.
35 35 Grewal, P. and Viswanathen, V.A. (2012). Liver cancer and alcohol. Clinics in Liver Disease 16 (4): 839–850.
36 36 Petrick, J.L., Campbell, P.T., Koshiol, J. et